In addition, a SIRT1 activator with 1000-fold greater potency compared to resveratrol called SRT1720 has been synthesized and reported to be efficacious against type 2 diabetes mellitus and cancer in mice [4]. The gene discussed is SIRT1; the disease is type 2 diabetes mellitus.